Nominees have been announced for Allicense Breakthrough Deal Awards
06 March 2015
Thomson Reuters analysts have disclosed 10 deals – five biopharma licensing and five M&A deals concluded in 2014 – as candidates for the Breakthrough Alliance Awards, with voting now open and the winner to be announced at this year's Allicense meeting in San Francisco.
Study Links Regulatory Changes during Development to Human Cerebral Cortex Evolution
06 March 2015
By comparing the epigenetic profiles of human, rhesus macaque, and mouse cerebral cortices during development, researchers from Yale School of Medicine and elsewhere uncovered enhancers and promoters that have increased activity in humans.
Activating genes on demand: Possible?
06 March 2015
Research data published in the journal Nature Methods suggest that it may be possible to develop gene therapies to prevent and treat diseases on a highly customisable, personalised level, Science Daily reported.
Biotech buys get pharma M&A off to flying start in 2015
06 March 2015
Competition for tomorrow's blockbuster drugs is now intense, inflating the cost of deals and pushing pharmaceuticals to centre stage in overall mergers and acquisitions (M&A).
Nuvo Research® Provides Business Update
05 March 2015
Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today provided a business update.
Which pharma needs its cash cow most? It's not just about numbers
05 March 2015
We regularly rank drugs by sales: Top-selling cancer treatments, top-selling diabetes drugs, top-selling heart meds--you get the picture. And if you follow the industry, you know the world's biggest prescription products already. AbbVie's Humira, for one, which brought in $12.5 billion last year.
SEC warns pharma companies to be honest about FDA correspondence
05 March 2015
The U.S. Securities and Exchange Commission's top enforcement chief warned on Tuesday that too many pharmaceutical companies are failing to accurately portray their dealings with federal drug regulators - a problem that could get them in trouble.
Want to stay out of trouble, pharma? Compliance, disclosure are key, SEC enforcer says
05 March 2015
Listen up, pharma companies: The Securities and Exchange Commission sees a few places where you might get yourselves into sticky situations. But there's an easy way to avoid trouble, and that's to beef up compliance and disclosure.
U.K. panel calls for innovation fund to break antibiotic discovery dam
05 March 2015
A panel set up by the United Kingdom government to review antimicrobial resistance has called for the creation of a global innovation fund to spur the discovery of new drugs. The idea is to counter years of underinvestment by public and private players in basic to mid-stage scientific research.
How will precision medicine handle privacy concerns moving forward?
04 March 2015
The U.S. Food and Drug Administration switched perspectives concerning patient-centric medicine on Feb. 19 when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom Syndrome – bringing it back to life after previous ethical/technical issues.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024